These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer. Nurgalieva Z; Xia R; Liu CC; Burau K; Hardy D; Du XL Am J Ther; 2010; 17(2):148-58. PubMed ID: 19417586 [TBL] [Abstract][Full Text] [Related]
60. Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study. Dimopoulos MA; Mateos MV; Richardson PG; Schlag R; Khuageva NK; Shpilberg O; Kropff M; Spicka I; Palumbo A; Wu KL; Esseltine DL; Liu K; Deraedt W; Cakana A; Van De Velde H; San Miguel JF Eur J Haematol; 2011 Jan; 86(1):23-31. PubMed ID: 20874823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]